Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Plos One|October 28, 2020
Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2Harlan Barker, Seppo ParkkilaPlos One|December 11, 2024
Bioinformatic characterization of ENPEP, the gene encoding a potential cofactor for SARS-CoV-2 infectionAntti Arppo, Harlan Barker, Seppo ParkkilaEuropean Journal of Haematology|July 11, 2018
Targeting Wnt signaling pseudokinases in hematological cancersHanna Karvonen, Robert Perttilä, Wilhelmiina Niininen, et al.Cells|August 7, 2019
Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 PathwaysHanna Karvonen, Harlan Barker, Laura Kaleva, et al.Journal of Medicinal Chemistry|December 27, 2023
Novel Drug Screening Assay for <i>Acanthamoeba castellanii</i> and the Anti-Amoebic Effect of Carbonic Anhydrase InhibitorsSusanna Haapanen, Harlan Barker, Fabrizio Carta, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|September 9, 2014
Drosophila melanogaster: a model organism for controlling Dipteran vectors and pestsReza Zolfaghari Emameh, Leo Syrjänen, Harlan Barker, et al.Parasites & Vectors|January 23, 2014
Bioinformatic analysis of beta carbonic anhydrase sequences from protozoans and metazoansReza Zolfaghari Emameh, Harlan Barker, Martti E E Tolvanen, et al.Nature Chemical Biology|November 1, 2024
A multiplex single-cell RNA-Seq pharmacotranscriptomics pipeline for drug discoveryAlice Dini, Harlan Barker, Emilia Piki, et al.Parasites & Vectors|September 2, 2014
Beta carbonic anhydrases: novel targets for pesticides and anti-parasitic agents in agriculture and livestock husbandryReza Zolfaghari Emameh, Harlan Barker, Vesa P Hytönen, et al.Cancers|August 7, 2021
Evaluating Targeted Therapies in Ovarian Cancer Metabolism: Novel Role for PCSK9 and Second Generation mTOR InhibitorsDafne Jacome Sanz, Juuli Raivola, Hanna Karvonen, et al.Pageof 3